secwatch / observer
8-K filed February 7, 2023, 6:59 PM ET ticker RGBP CIK 0001589150
other material confidence high sentiment negative materiality 0.60

Regen Biopharma files 1-for-1500 reverse stock split and reduces preferred voting power

Regen BioPharma Inc

item 5.03

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Regen BioPharma Inc: Amendment to Certificate of Designations reducing Series AA Preferred Stock votes per share to seven as of March 6, 2023 (effective 2023-03-06).

Change
charter amendment
Effective
2023-03-06
Exact text from the filing
An amendment to the Certificate of Designations of the Company’s Series AA Preferred Stock reducing that number of votes per share of Series AA Preferred stock to seven votes per share as of March 6, 2023.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Regen BioPharma Inc: Certificate of Change authorizing 1-for-1500 reverse stock split of all issued series of stock effective March 6, 2023 (effective 2023-03-06).

Change
charter amendment
Effective
2023-03-06
Exact text from the filing
A Certificate of Change authorizing 1 for 1500 reverse stock split of all issued series of stock.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Regen BioPharma Inc: Amendment to Certificate of Designations reducing Series NC Preferred Stock votes per share to 334 as of March 6, 2023 (effective 2023-03-06).

Change
charter amendment
Effective
2023-03-06
Exact text from the filing
An amendment to the Certificate of Designations of the Company’s Series NC Preferred Stock reducing that number of votes per share of Series NC Preferred stock to three hundred and thirty four votes per share as of March 6, 2023
View on SEC.gov

Browse all governance changes →

Regen BioPharma Inc filing history →

Source: SEC EDGAR
accession 0001607062-23-000078
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.